$NXTS 🚀 Up 63% Premarket 🔹 Nexentis announces international AI drug discovery initiative between MitoCareX Bio and Boltz 🤝 🔹 MITOLINE® platform + Boltz AI m

$NXTS 🚀 Up 63% Premarket 🔹 Nexentis announces international AI drug discovery initiative between MitoCareX Bio and Boltz 🤝 🔹 MITOLINE® platform + Boltz AI models will be combined for virtual screening of SLC transporter targets 🧬 🔹 Goal is to accelerate discovery of novel small-molecule scaffo…